Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)
Status:
Withdrawn
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
The study will assess the number of patients who become asymptomatic from clinical signs of
COVID19 and will assess the efficacy of Hydroxychloroquine (HCQ) and Azithromycine effects on
paucisymptomatic patients with ou without co-morbidities
Phase:
Phase 4
Details
Lead Sponsor:
Abderrahmane Mami Hospital
Collaborators:
Dacima Consulting Eshmoun Clinical Research Centre